Different decay of antibody response and VOC sensitivity in naïve and previously infected subjects at 15 weeks following vaccination with BNT162b2

BACKGROUND: COVID-19 vaccines have demonstrated effectiveness in reducing SARS-CoV-2 mild and severe outcomes. In vaccinated subjects with SARS-CoV-2 history, RBD-specific IgG and pseudovirus neutralization titers were rapidly recalled by a single BTN162b2 vaccine dose to higher levels than those in...

Descripción completa

Detalles Bibliográficos
Autores principales: Siracusano, Gabriel, Ruggiero, Alessandra, Bisoffi, Zeno, Piubelli, Chiara, Carbonare, Luca Dalle, Valenti, Maria Teresa, Mayora-Neto, Martin, Temperton, Nigel, Lopalco, Lucia, Zipeto, Donato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742572/
https://www.ncbi.nlm.nih.gov/pubmed/34998405
http://dx.doi.org/10.1186/s12967-021-03208-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742572/
https://www.ncbi.nlm.nih.gov/pubmed/34998405
http://dx.doi.org/10.1186/s12967-021-03208-3

Ejemplares similares